| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Yanan Gao, Yanting Liu, Sihui Zhao, Yishu Liu, Chen Zhang, Steve Hui, Mark Mikkelsen, Richard A E Edden, Xiao Meng, Bing Yu, Li Xia. MRS study on the correlation between frontal GABA+/Glx ratio and abnormal cognitive function in medication-naive patients with narcolepsy. Sleep medicine. vol 119. 2024-04-16. PMID:38626481. |
to compare the gaba+/glx (glutamate-glutamine) ratio in the prefrontal lobe under non-rapid eye movement sleep between patients with narcolepsy type 1 (nt1) and normal controls and explore the correlation between this difference and abnormal cognitive function, using synchronous electroencephalography-functional magnetic resonance spectroscopy (eeg-fmrs). |
2024-04-16 |
2024-04-19 |
Not clear |
| Oriella Gnarra, Julia van der Meer, Jan D Warncke, Livia G Fregolente, Elena Wenz, Kseniia Zub, Uchendu Nwachukwu, Zhongxing Zhang, Ramin Khatami, Sigrid von Manitius, Silvia Miano, Jens Acker, Mathias Strub, Robert Riener, Claudio L A Bassetti, Markus H Schmid. SPHYNCS: Feasibility of long-term monitoring with Fitbit smartwatches in central disorders of hypersomnolence and extraction of digital biomarkers in narcolepsy. Sleep. 2024-03-29. PMID:38551123. |
whereas narcolepsy type 1 (nt1) is well characterized, other cdh disorders lack precise biomarkers. |
2024-03-29 |
2024-03-31 |
human |
| Takashi Maruo, Shunsuke Takagi, Sunao Uchida, Hidehiko Takahashi, Genichi Sugihar. Temporal patterns of sleep latency in central hypersomnia and attention deficit hyperactivity disorder: a cluster analysis exploration using Multiple Sleep Latency Test. Frontiers in psychiatry. vol 15. 2024-03-28. PMID:38544845. |
the primary causes of eds are central hypersomnia, including narcolepsy type 1 (nt1), type 2 (nt2), and idiopathic hypersomnia (ih). |
2024-03-28 |
2024-03-30 |
Not clear |
| Chiara Del Bianco, Martina Ulivi, Claudio Liguori, Antonio Pisani, Nicola Biagio Mercuri, Fabio Placidi, Francesca Izz. Alexithymia, impulsiveness, emotion, and eating dyscontrol: similarities and differences between narcolepsy type 1 and type 2. Sleep and biological rhythms. vol 21. issue 1. 2024-03-12. PMID:38468909. |
the purposes of this study are to evaluate mood, impulsiveness, emotion, alexithymia, and eating behavior in patients with narcolepsy type 1 (nt1) and narcolepsy type 2 (nt2) compared to healthy controls and to investigate possible correlations between clinical-demographic data, polysomnographic parameters, and subjective questionnaires. |
2024-03-12 |
2024-03-14 |
human |
| Lisa Brunel, Enzo Brossaud, Julien Lioret, Antoine Jaffiol, Louison Vanderghote, Léa Cuisinier, Laure Peter-Derex, François Ricordeau, Marine Thieux, Marion Comajuan, Sabine Plancoulaine, Aurore Guyon, Patricia Franc. Effectiveness of an intervention program on physical activity in children with narcolepsy type 1. Sleep medicine. vol 116. 2024-03-09. PMID:38460419. |
physical activity (pa) is recommended as part of the management of narcolepsy type 1 (nt1). |
2024-03-09 |
2024-03-12 |
Not clear |
| Thi-Tuyet Trinh Tran, Thi-Hong Nhung Nguyen, Yves Dauvilliers, Roland Liblau, Xuan-Hung Nguye. Absence of specific autoantibodies in patients with narcolepsy type 1 as indicated by an unbiased random peptide-displayed phage screening. PloS one. vol 19. issue 3. 2024-03-05. PMID:38442093. |
narcolepsy type 1 (nt1) is an enigmatic sleep disorder characterized by the selective loss of neurons producing orexin (also named hypocretin) in the lateral hypothalamus. |
2024-03-05 |
2024-03-08 |
Not clear |
| Jari K Gool, Zhongxing Zhang, Rolf Fronczek, Pauline Amesz, Ramin Khatami, Gert Jan Lammer. Potential immunological triggers for narcolepsy and idiopathic hypersomnia: Real-world insights on infections and influenza vaccinations. Sleep medicine. vol 116. 2024-03-05. PMID:38442518. |
it is hypothesized that narcolepsy type 1 (nt1) develops in genetically susceptible people who encounter environmental triggers leading to immune-mediated hypocretin-1 deficiency. |
2024-03-05 |
2024-03-08 |
Not clear |
| Hilde T Juvodden, Dag Alnæs, Ingrid Agartz, Ole A Andreassen, Andres Server, Per M Thorsby, Lars T Westlye, Stine Knudsen-Heie. Cortical thickness and sub-cortical volumes in post-H1N1 narcolepsy type 1: A brain-wide MRI case-control study. Sleep medicine. vol 116. 2024-03-03. PMID:38432031. |
there was more than a 10-fold increase in the incidence of narcolepsy type 1 (nt1) after the h1n1 mass vaccination in 2009/2010 in several countries. |
2024-03-03 |
2024-03-06 |
Not clear |
| Xianhui Zhong, Yuqing Yuan, Qingqing Zhan, Tiantian Yin, Chengxin Ku, Yuxin Liu, Fen Wang, Yongmin Ding, Liying Deng, Wei Wu, Liang Xi. Cell-based versus enzyme-linked immunosorbent assay for detection of anti-Tribbles homolog 2 autoantibodies in Chinese patients with narcolepsy. Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine. 2024-02-06. PMID:38318919. |
narcolepsy type 1 (nt1) is attributed to a deficiency in cerebrospinal fluid orexin and is considered linked to autoimmunity. |
2024-02-06 |
2024-02-09 |
mouse |
| Marita Hovi, Ulrika Roine, Taina Autti, Hannu Heiskala, Timo Roine, Turkka Kirjavaine. Microstructural White Matter Abnormalities in Children and Adolescents With Narcolepsy Type 1. Pediatric neurology. vol 153. 2024-02-06. PMID:38320459. |
in 2010, the h1n1 pandemrix vaccination campaign was followed by a sudden increase in narcolepsy type 1 (nt1). |
2024-02-06 |
2024-02-09 |
Not clear |
| Nicolai Pagh-Berendtsen, Artem Pavlovskyi, Danel Flores Tellez, Christine Egebjerg, Mie Gunni Kolmos, Jessica Justinussen, Birgitte Rahbek Kornu. Downregulation of hypocretin/orexin after H1N1 Pandemrix vaccination of adolescent mice. Sleep. 2024-01-16. PMID:38227834. |
narcolepsy type 1 (nt1), characterized by the loss of hypocretin/orexin (hcrt) production in the lateral hypothalamus, has been linked to pandemrix vaccination during the 2009 h1n1 pandemic especially in children and adolescents. |
2024-01-16 |
2024-01-19 |
mouse |
| Lucie Barateau, Sofiene Chenini, Claire Denis, Quentin Lorber, Séverine Béziat, Isabelle Jaussent, Yves Dauvillier. Narcolepsy Severity Scale-2 and Idiopathic Hypersomnia Severity Scale to better quantify symptoms severity and consequences in Narcolepsy type 2. Sleep. 2024-01-10. PMID:38197577. |
narcolepsy type 2 (nt2) is an understudied central disorder of hypersomnolence sharing some similarities with narcolepsy type 1 (nt1) and idiopathic hypersomnia (ih). |
2024-01-10 |
2024-01-13 |
Not clear |
| Dandan Sheng, Peihong Li, Zheng Xiao, Xinru Li, Jing Liu, Bo Xiao, Weiping Liu, Luo Zho. Identification of bidirectional causal links between gut microbiota and narcolepsy type 1 using Mendelian randomization. Sleep. 2024-01-04. PMID:38174762. |
narcolepsy type 1 (nt1), characterized by cataplexy and orexin deficiency, is a rare and frequently debilitating neurological disorder. |
2024-01-04 |
2024-01-06 |
Not clear |
| Fabio Pizza, Luca Vignatelli, Stefano Vandi, Corrado Zenesini, Francesco Biscarini, Christian Franceschini, Elena Antelmi, Francesca Ingravallo, Emmanuel Mignot, Oliviero Bruni, Lino Nobili, Pierangelo Veggiotti, Raffaele Ferri, Giuseppe Plazz. Role of Daytime Continuous Polysomnography in the Diagnosis of Pediatric Narcolepsy Type 1. Neurology. vol 102. issue 1. 2024-01-02. PMID:38165365. |
narcolepsy type 1 (nt1) is still largely underdiagnosed or diagnosed too late in children. |
2024-01-02 |
2024-01-05 |
Not clear |
| Parya Valizadeh, Sara Momtazmanesh, Giuseppe Plazzi, Nima Rezae. Connecting the dots: An updated review of the role of autoimmunity in narcolepsy and emerging immunotherapeutic approaches. Sleep medicine. vol 113. 2023-12-21. PMID:38128432. |
narcolepsy type 1 (nt1) is a chronic disorder characterized by pathological daytime sleepiness and cataplexy due to the disappearance of orexin immunoreactive neurons in the hypothalamus. |
2023-12-21 |
2023-12-24 |
Not clear |
| Leila Khajavi, Xuan-Hung Nguyen, Clémence Queriault, Marianne Chabod, Lucie Barateau, Yves Dauvilliers, Matthias Zytnicki, Roland Libla. The transcriptomics profiling of blood CD4 and CD8 T-cells in narcolepsy type I. Frontiers in immunology. vol 14. 2023-12-11. PMID:38077397. |
the transcriptomics profiling of blood cd4 and cd8 t-cells in narcolepsy type i. narcolepsy type i (nt1) is a rare, life-long sleep disorder arising as a consequence of the extensive destruction of orexin-producing hypothalamic neurons. |
2023-12-11 |
2023-12-17 |
human |
| Petra Prochazkova, Karel Sonka, Radka Roubalova, Janet Jezkova, Sona Nevsimalova, Jitka Buskova, Radana Merkova, Tereza Dvorakova, Iva Prihodova, Simona Dostalova, Helena Tlaskalova-Hogenov. Investigation of anti-neuronal antibodies and disparity in central hypersomnias. Sleep medicine. vol 113. 2023-12-06. PMID:38056084. |
the study aims to determine whether serum autoantibody levels differ in patients with different types of central hypersomnias (narcolepsy type 1 and 2, nt1 and nt2; idiopathic hypersomnia, ih) and healthy controls and if the differences could suggest the participation of autoantibodies in disease pathogenesis. |
2023-12-06 |
2023-12-10 |
human |
| Luís Salazar, Paula Manuel Vieira, Inês Cascais, Sónia Figueiroa, Marta Rio. Quality of life in adolescents with narcolepsy type 1- a transversal study in a tertiary hospital. Sleep medicine. vol 113. 2023-12-06. PMID:38056083. |
- narcolepsy type 1 (nt1) is a rare chronic sleep disorder, usually arising by adolescence that negatively impacts quality of life. |
2023-12-06 |
2023-12-10 |
Not clear |
| Mojgan Atashi, Cristian D Gutierrez Reyes, Vishal Sandilya, Waziha Purba, Parisa Ahmadi, Md Abdul Hakim, Firas Kobeissy, Giuseppe Plazzi, Monica Moresco, Bartolo Lanuzza, Raffaele Ferri, Yehia Mechre. LC-MS/MS Quantitation of HILIC-Enriched Biomolecules. vol 13. issue 11. 2023-11-25. PMID:38002271. |
here, we investigate glycoproteins in narcolepsy type 1 (nt1) disease, a form of narcolepsy characterized by cataplexy-the sudden onset of muscle paralysis that is typically triggered by intense emotions. |
2023-11-25 |
2023-11-28 |
human |
| Mélanie Strauss, Lucie Griffon, Maxime Elbaz, Isabelle Arnulf, Mounir Chennaoui, Damien Lége. Altered reinforcement learning in Narcolepsy type I and other central disorders of hypersomnolence. Sleep medicine. vol 113. 2023-11-23. PMID:37995471. |
cognitive impairments are described in central disorders of hypersomnolence (cdh), but studies remain very limited and largely focused on narcolepsy type 1 (nt1). |
2023-11-23 |
2023-11-29 |
human |